PulseAugur
EN
LIVE 07:17:05
ENTITY Samsung Biologics

Samsung Biologics

PulseAugur coverage of Samsung Biologics — every cluster mentioning Samsung Biologics across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RELATIONSHIPS
TIMELINE
  1. 2026-07-20 funding Samsung Biologics announced its intention to acquire PolyPeptide Group AG for CHF 1.46 billion. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 2 TOTAL
  1. TOOL · CL_151503 ·

    Lingyi iTech repurchases shares; Samsung Biologics to acquire PolyPeptide Group AG; DeepSeek V4 release imminent

    Lingyi iTech has repurchased approximately 29.06 million shares, representing 0.36% of its total share capital, for a total of 399 million yuan as of July 17th. In a separate development, Samsung Biologics announced its…
  2. RESEARCH · CL_151504 ·

    Samsung Biologics to acquire PolyPeptide Group for CHF 1.46B

    Samsung Biologics has announced its intention to acquire PolyPeptide Group AG for CHF 1.46 billion in an all-cash deal. This strategic move aims to expand Samsung Biologics' capabilities beyond antibody and antibody-dru…